Company Filing History:
Years Active: 1994
Title: Innovator Masakazu Ebie and His Contribution to Parkinson's Disease Treatment
Introduction
Masakazu Ebie, an esteemed inventor based in Gifu, Japan, has made significant strides in the field of medicinal chemistry. He holds one patent that showcases his innovative contributions, particularly in developing treatments for Parkinson’s disease. Ebie's work in this area emphasizes both the importance of research and the potential for impactful medical advancements.
Latest Patents
Ebie's sole patent, titled "1,2,4-oxadiazole derivatives having monoamine oxidase B," represents a breakthrough in the development of therapeutic compounds. The patent outlines a 1,2,4-oxadiazole derivative characterized by a general formula where various groups, such as R¹ and R², depict a range of substituents including lower alkyl, phenyl, and various amino groups. This derivative is noted for its excellent monoamine oxidase-inhibitory activity, positioning it as a promising candidate for treating Parkinson's disease.
Career Highlights
Masakazu Ebie's career is highlighted by his work with Wakamoto Pharmaceutical Co., Ltd., a company known for its dedication to pharmaceutical research and development. Ebie's innovative research has contributed significantly to the understanding of neurodegenerative diseases and the pursuit of effective medicinal solutions.
Collaborations
Throughout his career, Ebie has worked alongside talented colleagues such as Hatsunori Toyofuku and Jun Matsumoto. These collaborations have fostered an environment of innovation and knowledge sharing, advancing their collective efforts towards medical breakthroughs.
Conclusion
Masakazu Ebie stands out as an influential figure in the field of medicinal chemistry, particularly through his innovative approaches to addressing Parkinson’s disease. His patent on 1,2,4-oxadiazole derivatives reflects his commitment to improving healthcare outcomes through targeted research. As he continues his work at Wakamoto Pharmaceutical Co., Ltd., Ebie’s contributions are sure to pave the way for future advancements in medicine.